An injection pen containing a semaglutide, commonly known under brand names such as Ozempic and Wegovy. Photo by Haberdoedas on Unsplash
A small fraction of private drug plan users drove more than a third of all prescription drug spending in Canada last year, according to new data from TELUS Health. The company's 2026 Drug Data Trends and National Benchmarks Report, released at the TELUS Health Annual Conference, found that just 2.1 ...
This article is available to registered HR News Canada members. Membership is free and provides full access to our independent reporting on workplace HR issues across Canada.
Already a member? Log in below
Todd Humber is an award-winning workplace journalist who has been covering the HR, employment law, and workplace safety beats for 25 years. He is the publisher and editor-in-chief at HR News Canada, published by North Wall Media.
HR News Canada is an independent source of workplace news for human resources professionals, managers, and business leaders. Published by North Wall Media.
©2026 All Right Reserved. Designed and Developed by North Wall Media